Yüklüyor......

Alterations in the p53 and MDM-2 genes are infrequent in clinically localized, stage B prostate adenocarcinomas.

Alterations in the p53 gene have been described in a variety of human malignant neoplasms. We have examined 29 stage B prostate carcinomas for alterations in the p53 gene and for amplification of the MDM-2 gene. No evidence of mutations in the conserved exons 5 to 8 was found by polymerase chain rea...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ittmann, M., Wieczorek, R., Heller, P., Dave, A., Provet, J., Krolewski, J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 1994
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1887392/
https://ncbi.nlm.nih.gov/pubmed/8053489
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!